Apollomics Inc. Class A Ordinary Shares (APLM) Dividend History

Apollomics Inc. is a biotechnology company focused on the development of innovative cancer therapies. It specializes in the discovery and advancement of immuno-oncology and targeted treatments, aiming to address unmet medical needs in oncology. The company's efforts include the development of clinical-stage drug candidates and leveraging its expertise in antibody engineering and immunology.

Website: https://www.apollomicsinc.com

Dividend History

Apollomics Inc. Class A Ordinary Shares currently does not pay dividends

Company News

  • Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Apollomics announced that its Phase 3 bridging trial of uproleselan in China for relapsed or refractory acute myeloid leukemia did not demonstrate a favorable benefit, with the median overall survival being lower in the uproleselan arm compared to the chemotherapy-only arm.

    GlobeNewswire Inc.
  • Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

    Shares of Salesforce, Inc. (NYSE: CRM) shares surged in pre-market trading after the company reported third-quarter financial results and issued FY24 guidance above estimates. Salesforce said third-quarter revenue increased 11% year-over-year to $8.72 billion, versus the consensus estimate of $8.72 billion, according to Benzinga Pro. The company reported quarterly earnings of $2.11 per share, which beat analyst estimates of $2.06 per share. Salesforce shares gained 9.4% to $252.00 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Aditxt, Inc. (NASDAQ: ADTX) shares rose 126.1% to $7.80 in pre-market trading. Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 74.7% to $0.5987 in pre-market trading. Connexa Sports recently reported a decline in sales for the second quarter. Clearmind Medicine Inc. (NASDAQ: CMND) rose 50.1% to $6.08 in pre-market trading after surging 22% on Wednesday. Clearmind Medicine recently announced results from its weight loss and metabolic disorder program. Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) shares surged 37.7% to $2.70 in pre-market trading after gaining over 3% on Wednesday. Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares ...

    Benzinga
    Featured Companies: ADTX CISS CMND CRM CYCC KTTA NMRA NVNI PSTG SGD VFS VVOS YOSH
  • Why Shares of Apollomics Are Up Friday

    The company just went public in March and recently received coverage and a buy rating from an analyst.

    The Motley Fool
Page data last updated 07/23/2025 03:42:19 UTC